These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 363063)

  • 1. The incomplete male.
    Savage MO; Grant DB
    Arch Dis Child; 1978 Sep; 53(9):701-3. PubMed ID: 363063
    [No Abstract]   [Full Text] [Related]  

  • 2. The syndromes of androgen resistance revisited.
    Pérez-Palacios G; Chávez B; Méndez JP; McGinley JI; Ulloa-Aguirre A
    J Steroid Biochem; 1987; 27(4-6):1101-8. PubMed ID: 3320547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose androgen therapy in male pseudohermaphroditism due to 5 alpha-reductase deficiency and disorders of the androgen receptor.
    Price P; Wass JA; Griffin JE; Leshin M; Savage MO; Large DM; Bu'Lock DE; Anderson DC; Wilson JD; Besser GM
    J Clin Invest; 1984 Oct; 74(4):1496-508. PubMed ID: 6480833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Male pseudohermaphroditism: a comparative study of one patient with 5 alpha-reductase deficiency and three patients with the complete form of testicular feminization.
    Kuttenn F; Mowszowicz I; Wright F; Baudot N; Jaffiol C; Robin M; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1979 Dec; 49(6):861-5. PubMed ID: 511977
    [No Abstract]   [Full Text] [Related]  

  • 5. Androgen resistance syndromes.
    Griffin JE; Leshin M; Wilson JD
    Am J Physiol; 1982 Aug; 243(2):E81-7. PubMed ID: 7051848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syndromes of androgen resistance.
    Griffin JE; Wilson JD
    Hosp Pract (Off Ed); 1987 Aug; 22(8):159-64, 166, 169 passim. PubMed ID: 3114273
    [No Abstract]   [Full Text] [Related]  

  • 7. The androgen receptor CAG repeat polymorphism.
    Zitzmann M; Gromoll J; Nieschlag E
    Andrologia; 2005 Dec; 37(6):216. PubMed ID: 16336253
    [No Abstract]   [Full Text] [Related]  

  • 8. Different aspects of 5 alpha-reductase deficiency in male pseudohermaphroditism and hypothyroidism.
    Mauvais-Jarvis P; Kuttenn F; Mowszowicz I; Wright F
    Clin Endocrinol (Oxf); 1981 May; 14(5):459-69. PubMed ID: 7307277
    [No Abstract]   [Full Text] [Related]  

  • 9. 5 alpha-reductase deficiency: an infrequent cause of male pseudohermaphroditism.
    Deslypere JP; Coucke W; Robbe N; Vermeulen A
    Acta Clin Belg; 1985; 40(4):240-6. PubMed ID: 4082862
    [No Abstract]   [Full Text] [Related]  

  • 10. Disorders of sexual development.
    Zajac JD; Warne GL
    Baillieres Clin Endocrinol Metab; 1995 Jul; 9(3):555-79. PubMed ID: 7575332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etiological diagnosis of undervirilized male/XY disorder of sex development.
    Atta I; Ibrahim M; Parkash A; Lone SW; Khan YN; Raza J
    J Coll Physicians Surg Pak; 2014 Oct; 24(10):714-8. PubMed ID: 25327912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The XY female in sport: the controversy continues.
    Hipkin LJ
    Br J Sports Med; 1993 Sep; 27(3):150-6. PubMed ID: 8242269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Male pseudohermaphroditism due to partial end-organ insensitivity to androgens.
    Barragry JM; Makin HL; Morris DV; Trafford DJ; Mason AS
    Clin Endocrinol (Oxf); 1977 Aug; 7(2):137-41. PubMed ID: 890997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, biochemical and morphologic diagnostic markers in an infant male pseudohermaphrodite patient with compound heterozygous mutations (G115D/R246W) in SRD5A2 gene.
    Fernández-Cancio M; Rodó J; Andaluz P; Martínez de Osaba MJ; Rodríguez-Hierro F; Esteban C; Carrascosa A; Audí L
    Horm Res; 2004; 62(5):259-64. PubMed ID: 15528927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the testicular abnormality in 5 alpha-reductase deficiency.
    Johnson L; George FW; Neaves WB; Rosenthal IM; Christensen RA; Decristoforo A; Schweikert HU; Sauer MV; Leshin M; Griffin JE
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1091-9. PubMed ID: 3760113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex reversal in an infant with Smith-Lemli-Opitz syndrome, type II: evidence for 5-alpha reductase deficiency.
    Salbert BA; Schwartz ID; Grunt JA
    J Pediatr Endocrinol Metab; 1996; 9(1):67-9. PubMed ID: 8887136
    [No Abstract]   [Full Text] [Related]  

  • 17. [Syndromes of resistance to androgens].
    Kuttenn F; Mowszowicz J; Wright F
    Ann Endocrinol (Paris); 1983; 44(5):327-31. PubMed ID: 6372640
    [No Abstract]   [Full Text] [Related]  

  • 18. [Steroid 5alpha-reductase deficiency].
    Tohda A
    Nihon Rinsho; 2006 Jun; Suppl 2():594-7. PubMed ID: 16817471
    [No Abstract]   [Full Text] [Related]  

  • 19. Prenatal testosterone and theory of mind development: Findings from disorders of sex development.
    Khorashad BS; Khazai B; Roshan GM; Hiradfar M; Afkhamizadeh M; van de Grift TC
    Psychoneuroendocrinology; 2018 Mar; 89():250-255. PubMed ID: 29398092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid 5 alpha-reductase deficiency and posterior urethral valves.
    Stanhope R; Milroy EJ; Brook CG
    Horm Res; 1986; 23(4):213-4. PubMed ID: 3699693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.